Transcription of Genetic Testing – Medicare Advantage Coverage Summary
{{id}} {{{paragraph}}}
Example: tourism industry
Genetic Testing – Medicare Advantage Coverage Summary
Page 1 of 23 UHC MA Coverage Summary : Genetic Testing Proprietary Information of UnitedHealthcare. Copyright 2020 United HealthCare Services, Inc. Coverage Summary Genetic Testing Policy Number: G-003 Products: UnitedHealthcare Medicare Advantage Plans Original Approval Date: 02/14/2008 Approved by: UnitedHealthcare Medicare Benefit Interpretation Committee Last Review Date: 08/18/2020 Related Medicare Advantage Policy Guidelines: BRCA1 and BRCA2 Genetic Testing Cytogenic Studies ( ) Genetic Testing for Lynch Syndrome Molecular Pathology Procedures for Human Leukocyte Antigen (HLA) Typing Molecular Pathology/ Genetic Testing Reported with Unlisted Codes Molecular Pathology/Molecular Diagnostics/ Genetic Testing Tier 2 Molecular Pathology Procedures This information is being distributed to you for personal reference.
the presence of microsatellite instability (MSI). All of these variant classes have demonstrated clinical utility. As such, NGS testing in cancer comprises a large heterogeneous group of assays that are substantially different from each other. Additionally,
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: